Orphan Drug Acquisition Advice

Client Challenge

A complicated pipeline with many drugs in different stages of development and launch.

A large biotech were seeking to acquire a new asset and drug candidate. The biotech had ample resources but no coordination between in-house departments.

P4A Solution

P4A analysed the current situation: Opportunity assessment in short / medium term required.

Key areas of our assessment included:
  • Analog assessment
  • Price setting
  • Willingness to pay
  • Competitive environment

The Successful Outcome

P4A obtained critical inputs for discussions with their commercial teams which included:

  • Better coordination among teams
  • Realistic negotiation position
  • Financially sound bid for target asset
P4A have given us credible and objective rationale that we’ve used to support decisions for acquisition of orphan therapies and devices.
Global Program Leader